Helix AI

Website: https://helixai.com/

HelixAI is a specialist scientific technology company focused on accelerating research and development for biopharmaceutical organizations. Its platform, JarvisAI, enables scientific teams to design and execute in silico R&D workflows that support a wide range of operations from early-stage drug discovery to scale-up and bioproduction. By integrating scientific data from public, private and client domains along with computational models and AI-driven orchestration, JarvisAI helps researchers explore hypotheses more efficiently and prioritize the most promising drug candidates for further development. This approach supports better, faster decision-making combined with optimization of scientific and wet-lab resources.

Qiagen

Website: https://digitalinsights.qiagen.com/

QIAGEN Digital Insights is the leading provider of genomic and clinical knowledge, analysis and interpretation software and services for scientists and clinicians. With over 25 years of experience in bioinformatics, 140,000 users worldwide, 100,000 citations in scientific papers and 5 million profiled patient cases, our quality knowledge and software will help you gain insights into everything from early discovery to clinical decision-making. Discover our curated knowledge solutions, bioinformatics software and services for better data management, collaboration and actionable insights. 

Qiagen

Website: https://digitalinsights.qiagen.com/

QIAGEN Digital Insights is the leading provider of genomic and clinical knowledge, analysis and interpretation software and services for scientists and clinicians. With over 25 years of experience in bioinformatics, 140,000 users worldwide, 100,000 citations in scientific papers and 5 million profiled patient cases, our quality knowledge and software will help you gain insights into everything from early discovery to clinical decision-making. Discover our curated knowledge solutions, bioinformatics software and services for better data management, collaboration and actionable insights. 

Qiagen

Website: https://digitalinsights.qiagen.com/

QIAGEN Digital Insights is the leading provider of genomic and clinical knowledge, analysis and interpretation software and services for scientists and clinicians. With over 25 years of experience in bioinformatics, 140,000 users worldwide, 100,000 citations in scientific papers and 5 million profiled patient cases, our quality knowledge and software will help you gain insights into everything from early discovery to clinical decision-making. Discover our curated knowledge solutions, bioinformatics software and services for better data management, collaboration and actionable insights. 

Cytocast

Website: https://www.cytocast.com/

Cytocast, a TechBio startup based in Budapest, Hungary, accelerates drug discovery by combining bioinformatics, AI, and large‑scale digital‑twin simulations to predict side effects at the start of R&D. Pharma, biotech and CRO teams use the Cytocast technology to de‑risk portfolios earlier and focus resources on safer candidates.

The CYTOCAST DIGITAL TWIN Platform™ models cellular systems to deliver breadth‑first side‑effect profiling for early‑stage small‑molecule programs, including combinations. Proteome‑based simulations reveal how candidates perturb cellular processes and provide actionable evidence to refine chemistries and improve safety. The platform has been validated through pilots with small and mid‑size partners. Currently, the following products are available for the clients’ tailored needs:

• Cytocast Screener™: Rank thousands of compounds by likely side effects to guide early discovery.
• Cytocast Optimizer™: After in vitro/in vivo, refine leads with comparative safety insights for preclinical decisions.
• Cytocast Nominator™: In‑depth analyses to support final candidate selection for trials.

Cytocast has raised €2.5M pre‑seed to date. We are opening a new €5M seed to expand product capabilities and market reach  with the goal of adoption at least 10 top‑100 pharma companies by 2027. Cytocast is a proud member of the Alliance for Artificial Intelligence in Healthcare (AAIH) and NVIDIA Inception.

SPOC Proteomics

Website: https://spoc.bio/

SPOC Biosciences’ sensor-integrated proteome on chip (SPOC) synthesizes 192-1152 proteins (full-length, peptides, miniproteins) or antibody (VHH, scFv, Fab) drugs directly on biosensor chips (SPR, MALDI) for library-scale kinetic affinity screening supporting AI-enabled and traditional antibody discovery pipelines. SPOC KinetiKx datasets include on-rate (ka), off-rate (kd), affinity (KD), and residence time (t1/2). SPOC’s proprietary Protein NanoFactory production system utilizes cell-free expression with simultaneous capture-purification directly onto SPR chips, reducing time and cost for library-scale dataset generation compared to traditional recombinant protein workflows. SPOC HyperKinetiKx SPR Product Suite supports antibody drug discovery efforts for affinity ranking (AffiRank), affinity maturation (AffiBoost), epitope binning (EpiScope), epitope mapping (AminoMap) and polyreactivity screening (ReactiScan). SPOC HyperSynaptiKx SPR Product Suite is specifically designed to produce on-demand, large-scale, high-resolution datasets for validation and training in AI-driven drug discovery and development. HyperSynaptiKx SPR assays include lab-in-the-loop services for wet lab testing in DBTL cycles (BuildLoopIQ) and customer-defined antibody vs target library-on-library screening (ContactIQ).